BioSpace News Archive

Policy

Ascletis’ Ravidasvir NDA Proposed for Priority Review by the CFDA

Ascletis Pharma Inc. announces today the New Drug Application (NDA) of Ravidasvir is on the List of Proposed Priority Review, according to the public notification by the China Food and Drug Administration (CFDA) on Oct 17th, 2018.

October 18, 2018
·
1 min read
Biotech Beach

Delta Dental Community Care Foundation awards $131,483 grant to San Ysidro Health

The organization serves over 95,000 patients annually through a network of medical, dental, and behavioral health clinics located across San Diego County.

October 18, 2018
·
2 min read
Business

Covance and Definiens Collaborate to Integrate Digital Pathology into Precision Medicine Design and Development

Alliance intended to establish image analysis-enabled companion diagnostics as standard for comprehensive targeted therapies

October 18, 2018
·
4 min read
Policy

Co-Diagnostics, Inc. Receives CE Mark for Zika Screening Test

Company’s Logix Smart™ Zika Test to be available for purchase with CE mark

October 18, 2018
·
4 min read
Pharm Country

Teleflex Announces Third Quarter 2018 Earnings Conference Call Information

Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, November 1, 2018

October 18, 2018
·
1 min read
Physical activity throughout pregnancy enhances physical and mental health and reduces risk of pregnancy complications

2019 Canadian Guideline for Physical Activity throughout Pregnancy outlines the right amount of physical activity to promote maternal, fetal and neonatal health.

October 18, 2018
·
2 min read
Business

Spectrum Pharmaceuticals Announces Dr. Francois Lebel as Chief Medical Officer

Veteran of the Biopharmaceutical Industry Joins as Company Advances Two Late-stage Oncology Therapies

October 18, 2018
·
5 min read
Drug Development

Merck’s KEYTRUDA® (pembrolizumab) in Combination with Pfizer’s Inlyta® (axitinib) Significantly Improved Overall Survival (OS) and Progression-free Survival (PFS) as First-Line Therapy for Advanced or Metastatic Renal Cell Carcinoma

KEYTRUDA is First Anti-PD-1 Therapy in Combination to Improve Both OS and PFS in Advanced or Metastatic RCC, the Most Common Type of Kidney Cancer

October 18, 2018
·
25 min read
Drug Development

Novaliq Announces Positive Topline Results for Its CyclASol® Phase 2B/3 Essence Trial in Patients with Dry Eye Disease

The ESSENCE trial met its primary endpoint at 4 weeks and demonstrated superiority of CyclASol® over vehicle in change from baseline on corneal fluorescein staining

October 18, 2018
·
6 min read
Business

Former DEA Agent and Inspiration for Netflix’s Narcos Series Announced as Verde Techologies’ Newest Advisory Council Member

COMPANY ALSO RECEIVES PRESTIGIOUS AWARD FOR ITS EFFORTS TO TACKLE THE OPIOID EPIDEMIC

October 18, 2018
·
3 min read